Search details
1.
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
Invest New Drugs
; 37(4): 738-747, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30993587
2.
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
Invest New Drugs
; 36(6): 1016-1025, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29611022
3.
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.
Int J Cancer
; 140(1): 208-215, 2017 Jan 01.
Article
in English
| MEDLINE | ID: mdl-27599876
4.
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 215-24, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25363205
5.
A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Invest New Drugs
; 33(1): 177-86, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25323060
6.
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
Invest New Drugs
; 33(4): 911-20, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25990659
7.
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.
Invest New Drugs
; 33(3): 621-31, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25822109
8.
Multiple gene aberrations and breast cancer: lessons from super-responders.
BMC Cancer
; 15: 442, 2015 May 29.
Article
in English
| MEDLINE | ID: mdl-26021831
9.
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study.
Lancet Oncol
; 15(6): 656-66, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24746841
10.
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.
Cancer
; 120(14): 2164-73, 2014 Jul 15.
Article
in English
| MEDLINE | ID: mdl-24752867
11.
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors.
Invest New Drugs
; 32(1): 154-9, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-23609829
12.
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy.
Invest New Drugs
; 32(4): 717-22, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24764123
13.
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.
Oncologist
; 18(12): 1315-20, 2013.
Article
in English
| MEDLINE | ID: mdl-24153239
14.
Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies.
Invest New Drugs
; 31(5): 1192-200, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23907406
15.
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.
Invest New Drugs
; 31(4): 918-26, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23179336
16.
Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.
Cancer
; 117(22): 5142-50, 2011 Nov 15.
Article
in English
| MEDLINE | ID: mdl-21538342
17.
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors.
Clin Cancer Res
; 27(5): 1247-1255, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33115815
18.
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
Clin Cancer Res
; 26(21): 5579-5587, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-33055173
19.
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
J Hematol Oncol
; 12(1): 145, 2019 12 30.
Article
in English
| MEDLINE | ID: mdl-31888672
20.
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.
JCO Precis Oncol
; 22018.
Article
in English
| MEDLINE | ID: mdl-32913996